Titlebook: Chemotherapy for Leukemia; Novel Drugs and Trea Takanori Ueda Book 2017 Springer Nature Singapore Pte Ltd. 2017 Acute promyelocytic leukemi

elastic

溺爱

https://doi.org/10.1007/978-3-642-24440-7eatment strategy for B-CLL. The addition of anti-CD20 antibody to its management has remarkably improved the survival of B-CLL patients. Fludarabine, cyclophosphamide, and rituximab (FCR) is a standard treatment for physically fit patients without . defects, while bendamustine and rituximab (BR) is

意见一致

DEAF